Pullman, WA, United States of America

Fred R Rurangirwa

This inventor holds 3 USPTO granted patents. Top assignee: University of Florida Research Foundation Inc.. Active years: 2001-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fred R Rurangirwa. Retrieved from https://idiyas.com/inventor/fred-r-rurangirwa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 66.7

Average Co-Inventor Count = 10.2

ph-index = 3

Forward Citations = 45(Granted Patents)


Company Filing History:


Years Active: 2001-2003

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Fred R Rurangirwa

Introduction

Fred R Rurangirwa is a notable inventor based in Pullman, WA (US). He has made significant contributions to the field of biotechnology, particularly in the development of nucleic acid vaccines. With a total of 3 patents, his work focuses on innovative solutions to combat rickettsial diseases.

Latest Patents

Rurangirwa's latest patents include groundbreaking research on nucleic acid vaccines against rickettsial diseases. These vaccines contain genes designed to protect both animals and humans from these diseases. Additionally, he has described polypeptides and methods for using these polypeptides to detect antibodies to pathogens, further enhancing the diagnostic capabilities in this area.

Career Highlights

Fred R Rurangirwa is affiliated with the University of Florida Research Foundation Inc., where he continues to advance his research. His work has garnered attention for its potential impact on public health and veterinary medicine.

Collaborations

Rurangirwa has collaborated with esteemed colleagues such as Anthony F Barbet and Michael V Bowie, contributing to a rich environment of innovation and research.

Conclusion

Fred R Rurangirwa's contributions to the field of biotechnology through his patents and research are invaluable. His work in developing nucleic acid vaccines represents a significant advancement in the fight against rickettsial diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…